The estimated Net Worth of Emily Buxton is at least $105 Mille dollars as of 20 May 2013. Emily Buxton owns over 750 units of Orthofix Medical Inc stock worth over $105,079 and over the last 12 years Emily sold OFIX stock worth over $0.
Sign up
Emily Buxton OFIX stock SEC Form 4 insiders trading
Emily has made over 1 trades of the Orthofix Medical Inc stock since 2013, according to the Form 4 filled with the SEC. Most recently Emily bought 750 units of OFIX stock worth $19,890 on 20 May 2013.
The largest trade Emily's ever made was buying 750 units of Orthofix Medical Inc stock on 20 May 2013 worth over $19,890. On average, Emily trades about 188 units every 0 days since 2013. As of 20 May 2013 Emily still owns at least 6,039 units of Orthofix Medical Inc stock.
You can see the complete history of Emily Buxton stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Emily Buxton's mailing address?
Emily's mailing address filed with the SEC is C/O ORTHOFIX INTERNATIONAL NV, 3451 PLANO PARKWAY, LEWISVILLE, TX, 75056.
Insiders trading at Orthofix Medical Inc
Over the last 21 years, insiders at Orthofix Medical Inc have traded over $19,062,472 worth of Orthofix Medical Inc stock and bought 182,076 units worth $5,806,101 . The most active insiders traders include Stuart Essig, Charles R. Kummeth e Alexis V Lukianov. On average, Orthofix Medical Inc executives and independent directors trade stock every 53 days with the average trade being worth of $179,237. The most recent stock trade was executed by Kevin J. Kenny on 8 January 2024, trading 5,959 units of OFIX stock currently worth $103,687.
What does Orthofix Medical Inc do?
orthofix international began in a small farmhouse in verona italy in 1980 when orthopedic researcher giovanni de bastiani recognized the bone’s natural repair capability, a concept he called “dynamization” and with that in mind, he created the first external fixation device. today, orthofix has grown to more than 900 employees with locations in the u.s., italy, germany, france, the uk, brazil, australia and puerto rico. our products help patients in 70 countries around the world. the company is comprised of four strategic business units; biostim, biologics, extremity fixation and spine fixation. our products are widely distributed via the company's sales representatives, distributors and subsidiaries. at orthofix we are committed to clinical research and driven by new product introductions. we are proud of our strong partnerships with organizations such as the texas scottish rite hospital for children in dallas and the musculoskeletal transplant foundation. we take pride in developing
What does Orthofix Medical Inc's logo look like?
Complete history of Emily Buxton stock trades at Orthofix Medical Inc
Orthofix Medical Inc executives and stock owners
Orthofix Medical Inc executives and other stock owners filed with the SEC include:
-
Jon Serbousek,
President, Chief Executive Officer, Director -
Douglas Rice,
Chief Financial Officer -
Kimberley Elting,
Chief Legal and Administrative Officer -
Jon C. Serbousek,
Pres, CEO & Director -
Kevin J. Kenny,
Pres of Global Spine Bus. -
Douglas C. Rice,
CFO & Chief Accounting Officer -
Kimberley A. Elting,
Chief Legal & Devel. Officer -
Ronald Matricaria,
Independent Chairman of the Board -
Paul W. Gonsalves,
Pres of Global Orthofix Orthopedics -
Michael Paolucci,
Independent Director -
James Hinrichs,
Independent Director -
Alexis Lukianov,
Independent Director -
Maria Sainz,
Independent Director -
Lilly Marks,
Independent Director -
John Sicard,
Independent Director -
Paul Gonsalves,
President of the Orthofix Global Extremities -
Jason Hannon,
Independent Director -
Kevin Kenny,
President, Global Orthofix Spine -
Suzanne Armstrong,
VP of HR -
Jill Mason,
Chief Ethics & Compliance Officer -
Dan E. Yarbrough,
VP of Investor Relations -
Tim McGuire,
Chief Information Officer -
Dr. James T. Ryaby B.A., Ph.D., Chemistry,
Chief Scientific Officer -
Roberto Donadello,
Sr. VP, Global Operations -
Michael Finegan,
-
Robert Allen Ii Goodwin,
President Biologics -
Rice Doug,
CFO -
Raymond Fujikawa,
President Spine Fixation -
Davide Bianchi,
President, Global Extremities -
Guy J Jordan,
Director -
Anthony Francis Martin,
Director -
Luke T Faulstick,
Director -
Bradley V. Niemann,
President of Global Spine -
Jeffrey Schumm,
SVP,General Counsel -
Charles R. Kummeth,
-
John J. Bostjancic,
CFO -
Keith Valentine,
President & CEO -
John B Iii Henneman,
-
Patrick L Keran,
Chief Legal Officer -
Stuart Essig,
Director -
Brad Mason,
CEO -
Massimo Calafiore,
President & CEO -
Eric M Brown,
Sr.V.P. of Sales and Marketing -
De Paul Alberto C Dabreu,
Director -
John W Littlechild,
Director -
Cooper Robert Gaines,
Chairman -
Davey Scoon,
Director -
Emily Buxton,
Int. Chief Financial Officer -
James Gero,
Director -
Wartburg Walter P Von,
Director -
Randy H Thurman,
Director -
Mark A Heggestad,
Chief Financial Officer -
Michael Mainelli,
Director -
Scott Dodson,
President, Orthopedics -
Kenneth R Weisshaar,
Director -
Kathleen T Regan,
Director -
Thomas M Hein,
Chief Financial Officer -
Gary Henley,
President, Americas Division -
Peter J Hewett,
Director -
Oliver Burckhardt,
President, International Div -
Alan Milinazzo,
Chief Operating Officer -
Galvin Mould,
President, International Div -
Frederik Hartsuiker,
Director -
Edgar Wallner,
Deputy Chairman -
Peter Clarke,
Executive Vice President -
Robert S Vaters,
Chief Financial Officer -
Stefan Widensohler,
Director -
Thomas J Kester,
Director -
Timothy M Adams,
Chief Financial Officer -
Charles Federico,
President & CEO -
Vicente Trelles,
SVP-Worldwide Operations -
Eric Brown,
President, Spinal Stimulation -
Michael Simpson,
President, Orthofix Inc. -
Bradley R Mason,
President of Breg -
Brian Mc Collum,
Interim CFO -
Jerry Benjamin,
Director -
Raymond C Kolls,
VP & General Counsel -
Bryan Mcmillan,
President, Spine GBU -
Brad Lee,
President, Breg -
Luigi Ferrari,
President, Int'l Fixation -
Shweta Maniar,
-
Julie Andrews,
CFO -
Patrick Fisher,
President, Global Orthopedics -
Jorge Andres Cedron,
CLO -
Wayne Burris,
-
Thomas A. West,
Director -
Puja Leekha,
CECO & Interim CLO -
Geoffrey C Gillespie,
CAO -
Catherine M Burzik,
-
Alan Lee Bazaar,
-
Max Reinhardt,
President, Global Spine